Your browser doesn't support javascript.
loading
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.
Bychkovsky, Brittany; Laws, Alison; Katlin, Fisher; Hans, Marybeth; Knust Graichen, Mary; Pace, Lydia E; Scheib, Rochelle; Garber, Judy E; King, Tari A.
Affiliation
  • Bychkovsky B; Harvard Medical School, Boston, MA, USA.
  • Laws A; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Katlin F; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hans M; Harvard Medical School, Boston, MA, USA.
  • Knust Graichen M; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Pace LE; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Scheib R; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Garber JE; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Breast Cancer Res Treat ; 193(2): 417-427, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35378642

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article Affiliation country: United States Country of publication: Netherlands